Are Cancer Biosimilars Similar and Significant Enough to Deserve More Attention?
JAMA network open(2023)
Abstract
Xingxian Luo, PhD; Xin Du, MSc; Zhuangqi Li, MSc; Jingwen Liu, MSc; Xufeng Lv, MSc; Haoran Li, BS; Qixiang Guo, MSc; Cen Wang, PhD; Xuecai Xue, MSc; Kaidi Le, MSc; Xiaomeng Jiang, MSc; Lin Huang, PhD; Yue Yang, PhD
MoreTranslated text
Key words
cancer biosimilars biosimilars
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined